Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Toxicol Lett ; 211(3): 239-45, 2012 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-22516760

RESUMEN

Chloropicrin is an aliphatic volatile nitrate compound that is mainly used as a pesticide. It has several toxic effects in animals and can cause irritating and other health problems in exposed humans. Since the mode of chloropicrin action is poorly understood, the aim of this study was to investigate molecular responses underlying chloropicrin toxicity. We used human retinal pigment epithelial cells (ARPE-19) as a model cell type because the eyes are one of the main target organs affected by chloropicrin exposure. Transmission electron microscopy images revealed that exposure to a chloropicrin concentration that decreased cell viability by 50%, evoked the formation of numerous electron-lucent, non-autophagy vacuoles in the cytoplasm with dilatation of the endoplasmic reticulum (ER). Lower concentrations led to the appearance of more electron-dense vacuoles, which contained cytoplasmic material and were surrounded by a membrane resembling autophagy vacuoles. According to immunoblotting analyses chloropicrin increased the amount of the ER-stress related proteins, Bip (about 3-fold compared to the controls), IRE1α (2.5-fold) and Gadd 153/Chop (2.5-fold), evidence for accumulation of misfolded proteins in the ER. This property was further confirmed by the increase of reactive oxygen species (ROS) production (2-2.5-fold), induction of heme oxygenase-1 (about 6-fold), and increase in the level of the tumour suppressor protein p53 (2-fold). Thus, the cytotoxicity of chloropicrin in the retinal pigment epithelium is postulated to be associated with oxidative stress and perturbation of the ER functions, which are possibly among the mechanisms involved in oculotoxicity of chloropicrin.


Asunto(s)
Estrés del Retículo Endoplásmico/efectos de los fármacos , Células Epiteliales/patología , Hidrocarburos Clorados/toxicidad , Insecticidas/toxicidad , Epitelio Pigmentado de la Retina/patología , Autofagia , Western Blotting , Línea Celular , Supervivencia Celular/efectos de los fármacos , Electroforesis en Gel de Poliacrilamida , Retículo Endoplásmico/efectos de los fármacos , Retículo Endoplásmico/metabolismo , Retículo Endoplásmico/ultraestructura , Células Epiteliales/efectos de los fármacos , Proteínas de Choque Térmico/biosíntesis , Hemo Oxigenasa (Desciclizante)/metabolismo , Humanos , Microscopía Electrónica de Transmisión , Especies Reactivas de Oxígeno/metabolismo , Epitelio Pigmentado de la Retina/efectos de los fármacos , Proteína p53 Supresora de Tumor/biosíntesis , Vacuolas/efectos de los fármacos , Vacuolas/ultraestructura
2.
Toxicol Lett ; 178(3): 152-9, 2008 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-18440733

RESUMEN

Although benzo(a)pyrene (BP) induces apoptosis in vitro in murine Hepa1c1c7 cells and in vivo indications of apoptosis in rat lung exist, related cellular mechanisms in human cells are not known. p53 protein participates in several apoptotic processes. We found that BP induces cell death in human MCF-7 breast adenocarcinoma cells at 48 and 72h but not in human A549 lung carcinoma cells. BP did not induce measurable caspase-3-like protease activity or internucleosomal DNA fragmentation in either cell types. However, procaspase-7 cleavage in MCF-7 cells by BP-treatment indicates activation of caspase-7 meaning that apoptosis is most likely involved in BP-induced MCF-7 cell death. BP-7,8-dihydrodiol-9,10-epoxide (BPDE)-DNA adducts and level of p53 protein increased dose-dependently, but more extensively in MCF-7 cells. Phosphorylation of p53 protein at serines 15, 20, 46 and 392 increased in MCF-7 cells. Increase in phosphorylation at serine 392 was clear already at 24h by 1 microM concentration of BP. Increase of phosphorylation at other sites occurred only with higher concentrations or at later time points in relation to the increase of p53 protein. These results suggest that serine 392 phosphorylation is the first stabilizing event of p53 associated with BP exposure and subsequent cell death in MCF-7 cells.


Asunto(s)
Adenocarcinoma/patología , Apoptosis/efectos de los fármacos , Benzo(a)pireno/toxicidad , Neoplasias de la Mama/patología , Carcinógenos/toxicidad , Serina/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Línea Celular Tumoral/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Aductos de ADN , Daño del ADN , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Humanos , Fosforilación/efectos de los fármacos
3.
Phytomedicine ; 13(4): 240-5, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16492526

RESUMEN

The neuroprotective ability of the aqueous crude extract of Bryothamnion triquetrum (S. G. Gmelin) Howe and its cinnamic acids was studied in GT1-7 cells exposed to the combination of chemical hypoxia (KCN 3 mM) and aglycemia conditions. These ischemia-like conditions provoked acute and delayed cytotoxicity in GT1-7 cells if extended for more than 90 min. The extract was able to protect from the cell death produced by severe (180 min) chemical hypoxia/aglycemia insult, which cannot be related to its glucose content, and also reduced the cytotoxicity and early production of free radicals produced by mild (105 min) insult. Results showed that some of these protective effects of the extract are partially related to the presence of ferulic acid. The data additionally suggest that neuroprotection exerted by the extract is related to its ability to reduce free-radical generation by mechanisms different from the direct scavenging of the radical entities.


Asunto(s)
Cinamatos/farmacología , Ácidos Cumáricos/farmacología , Hipotálamo/citología , Fármacos Neuroprotectores/farmacología , Rhodophyta/química , Análisis de Varianza , Animales , Hipoxia de la Célula/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Radicales Libres/metabolismo , Glucosa/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Ratones , Rodaminas/metabolismo , Factores de Tiempo , Pruebas de Toxicidad
4.
Toxicol Lett ; 160(3): 227-32, 2006 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-16125343

RESUMEN

We have previously shown that although glutamate alone has no effects on viability of mouse hypothalamic GT1-7 cells, it clearly enhances Pb2+-induced cytotoxicity. It is likely that Pb2+ must enter cells to exert most of its toxic effects. Pb2+ is known to substitute for Ca2+ in many cellular processes. Therefore, we studied the uptake mechanisms of Pb2+ into GT1-7 neuronal cells with a special focus on the role of extracellular calcium (Ca2+), voltage-sensitive calcium channels (VSCCs) and glutamate. Basal uptake of Pb2+ (1 microM or 10 microM), i.e. without any external stimulus, clearly increased in nominally Ca2+-free buffer and was partially abolished by 13 mM Ca2+ when compared to uptake in the presence of a physiological concentration of extracellular Ca2+ (1.3 mM). Depolarization by 25 mM K+, or antagonists of VSCCs, verapamil (10 microM) or flunarizine (10 microM) had no clear effect on basal Pb2+ uptake. Glutamate (1 mM) increased Pb2+ uptake, but only when cells were treated with 1 microM Pb2+ in the presence of 1.3 mM Ca2+. Our data suggest that Pb2+ competes for the same cellular uptake pathways with Ca2+, although not via VSCCs. In addition, enhancement of Pb2+-induced neurotoxicity by glutamate may be due to increased neuronal uptake of Pb2+.


Asunto(s)
Calcio/farmacología , Ácido Glutámico/farmacología , Hipotálamo/metabolismo , Plomo/farmacocinética , Neuronas/efectos de los fármacos , Animales , Calcio/metabolismo , Línea Celular , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Colorantes Fluorescentes , Hipotálamo/citología , Hipotálamo/efectos de los fármacos , Plomo/toxicidad , Ratones , Neuronas/metabolismo , Compuestos Organometálicos/farmacocinética , Compuestos Organometálicos/toxicidad , Espectrometría de Fluorescencia
5.
Phytomedicine ; 10(1): 39-47, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12622462

RESUMEN

The current investigation focuses attention on the neuroprotective and antioxidant properties of aqueous extracts from Halimeda incrassata (Hi) and Bryothamniom triquetrum (Bt) in the mouse immortalized hypothalamic GT1-7 cell line. Under basal oxidative conditions, Hi extract reduces intracellular reactive oxygen species production, as assessed by 2',7'-dichlorofluorescein fluorescence, while Bt extract does not contribute to basal ROS generation. Both extracts, at concentrations higher than 0.20 mg/ml, exert protection against hydrogen peroxide-mediated cell death, although only Hi extract can additionally prevent hydrogen peroxide-induced ROS production. The two seaweed aqueous extracts, at concentrations higher than 0.05 mg/ml, also display protection against neuronal death induced by methyl mercury chloride, as well as against methyl mercury chloride-mediated ROS generation. None of the extracts increase GSH intracellular pools, in basal conditions, after depleting its levels with either hydrogen peroxide or methyl mercury chloride. Some comments on the probable targets of the neuroprotection exerted by these two extracts are included in this paper.


Asunto(s)
Hipotálamo/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fitoterapia , Extractos Vegetales/farmacología , Algas Marinas , Animales , Línea Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Peróxido de Hidrógeno , Hipotálamo/citología , Compuestos de Metilmercurio , Ratones , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Especies Reactivas de Oxígeno/metabolismo
6.
Neurotoxicology ; 19(4-5): 669-74, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9745927

RESUMEN

Oxidative stress may be an important factor in several pathological brain conditions. A contributing factor in many such conditions is excessive glutamate release, and subsequent glutamatergic neuronal stimulation, that causes increased production of reactive oxygen species (ROS), oxidative stress, excitotoxicity and neuronal damage. Glutamate release is also associated with illnesses such as Alzheimer's disease, stroke, and brain injury. Glutamate may interact with an environmental toxin, lead, and this interaction may result in neuronal damage. Glutamate-induced ROS production is greatly amplified by lead in cultured neuronal cells. Alterations in protein kinase C (PKC) activity seem to be important both for glutamate-induced ROS production, and for the amplification of glutamate-induced ROS production by lead. It is possible that the neurotoxic effects of lead are amplified through glutamate-induced neuronal excitation. Cholinergic stimulation can also trigger ROS production in neuronal cells. PKC seems to play a key-role also in cholinergic-induced ROS production superoxide anion being the primary reactive oxygen species. There seems to be a close relationship between the responses of cholinergic muscarinic and glutamatergic receptors because glutamate receptor antagonists inhibit cholinergic-induced activation of human neuroblastoma cells. Glutamatergic neuronal stimulation may be a common final pathway in several brain conditions in which oxidative stress and ensuing excitotoxicity plays a role.


Asunto(s)
Ácido Glutámico/farmacología , Plomo/farmacología , Neuronas/metabolismo , Sistema Nervioso Parasimpático/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Animales , Células Cultivadas , Humanos , Neuronas/efectos de los fármacos , Sistema Nervioso Parasimpático/citología , Sistema Nervioso Parasimpático/efectos de los fármacos
7.
Free Radic Biol Med ; 24(2): 377-84, 1998 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-9433914

RESUMEN

The role of extracellular calcium in glutamate-induced oxidative stress, and the role of glutamatergic neuronal stimulation and oxidative stress in lead neurotoxicity were explored in mouse hypothalamic GT1-7 cells. Glutamate increased the production of reactive oxygen species (ROS) whether or not extracellular calcium was present. Glutamate-induced ROS production was amplified by lead acetate (PbAc), but only in the absence of extracellular calcium. However, PbAc on its own did not increase the production of ROS. A PKC inhibitor (Ro 31-8220) and superoxide dismutase (SOD) abolished the amplification of glutamate-induced production of ROS by PbAc, but did not inhibit ROS production induced by glutamate alone. Both glutamate and PbAc decreased the levels of intracellular glutathione (GSH), and amplified each other's effect on GSH depletion. Glutamate did not decrease cell viability, whereas the cytotoxicity of PbAc was amplified by glutamate. Extracellular calcium, a PKC inhibitor, or SOD did not modify the effects of glutamate, PbAc or their combination on the levels of GSH or cell viability. These data indicate that in GT1-7 cells extracellular calcium is not essential for glutamate-induced ROS production, which is amplified by PbAc, but only without extracellular calcium. The joint cytotoxicity of glutamate and PbAc is mainly induced by PbAc, preferentially through mechanisms other than ROS production.


Asunto(s)
Calcio/fisiología , Ácido Glutámico/farmacología , Hipotálamo/metabolismo , Compuestos Organometálicos/farmacología , Estrés Oxidativo/efectos de los fármacos , Animales , Calcio/farmacología , Línea Celular , Inhibidores Enzimáticos/farmacología , Espacio Extracelular/metabolismo , Glutatión/metabolismo , Hipotálamo/efectos de los fármacos , Indoles/farmacología , Ratones , Proteína Quinasa C/antagonistas & inhibidores , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/farmacología
8.
Toxicol Lett ; 102-103: 363-7, 1998 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-10022280

RESUMEN

Increased glutamate release is associated with serious neurological disorders such as epilepsy, stroke, Alzheimer's disease and other brain injuries. Excessive glutamate release and subsequent glutamatergic neuronal stimulation increase the production of reactive oxygen species (ROS), which in turn induce oxidative stress, excitotoxicity and neuronal damage. A number of studies have shown that co-exposure of neuronal cells to glutamate, and an environmental toxin, lead, can greatly amplify glutamate excitotoxicity and cell death through apoptosis or necrosis. Even though the mechanisms of excitotoxicity or those of glutamate-lead interactions have not been exhaustively delineated, there is ample evidence to suggest that increased production of ROS may play an important role in both events. Subsequently, increased DNA binding of redox-regulated transcription factors, NF-kappaB and AP-1, seems to be associated with these events. Induction of an immediate early gene, c-fos, is seen in neuronal cells exposed to glutamate or lead. Immediate early genes are important in regulating the expression of other neuronal genes; Elevated expressions of the genes encoding Hsp70 or cyclo-oxygenase-2 seem to be involved in the apoptosis or necrosis induced by glutamate, and may be associated with induction of several of the genes in cells exposed to lead, or to the glutamate-lead combination. Further studies are required to clarify the mechanisms of glutamate-lead neurotoxicity.


Asunto(s)
Ácido Glutámico/toxicidad , Plomo/toxicidad , Neuronas/efectos de los fármacos , Estrés Oxidativo , Animales , Apoptosis/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Humanos , FN-kappa B/metabolismo , Neuronas/metabolismo , Especies Reactivas de Oxígeno/metabolismo
9.
Life Sci ; 60(21): 1905-14, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9155001

RESUMEN

Stimulation of human SH-SY5Y neuroblastoma cells by a muscarinic receptor agonist, carbachol (CCh; 1 mM), elevated levels of free intracellular calcium and subsequently increased the production of reactive oxygen species (ROS). Quinuclidinylbenzilate (QNB) binding increased at 1 h after CCh, but returned back to the control level at 3 h. Production of ROS increased, however, during the 3 h time period. CCh also increased the translocation of protein kinase C (PKC) to the membrane. ROS production was completely blocked by atropine and a PKC inhibitor, Ro 31-8220. These results show that increased ROS production was a result of muscarinic receptor stimulation, and that PKC had an active role in this cellular stimulation. ROS production upon cellular stimulation by CCh was completely inhibited also by superoxide dismutase, and partially by catalase, indicating that the formation of superoxide anion dominated in cholinergic-induced generation of ROS in human neuroblastoma cells. These results also show that muscarinic stimulation causes sustained ROS production in human neuroblastoma cells. The slow increase in ROS production by CCh suggest a stepwise cascade of events leading to oxidative stress with a triggering role of cholinergic muscarinic receptors in this process.


Asunto(s)
Carbacol/farmacología , Agonistas Muscarínicos/farmacología , Especies Reactivas de Oxígeno/metabolismo , Transporte Biológico , Calcio , Humanos , Neuroblastoma/metabolismo , Neuroblastoma/patología , Forbol 12,13-Dibutirato/metabolismo , Proteína Quinasa C/metabolismo , Quinuclidinil Bencilato/metabolismo , Células Tumorales Cultivadas
10.
Toxicol Lett ; 82-83: 399-405, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8597084

RESUMEN

Glutamate is a ubiquitous neurotransmitter which causes excess neuronal excitotoxicity and neurodegenerative insults such as stroke, trauma and seizures. A salient feature of the activation of glutamate receptors is the induction of oxidative burst. Moreover, glutamate stimulates Ca2+ influx and translocates protein kinase C (PKC). PKC mediates cellular processes mediated via phosphorylations which may be essential for oxidative burst in many cells. Subsequent oxidative stress may be a causal factor of neurodegenerative diseases. Increased glutamate release and oxidative burst may thus both be essential in the cascade of events leading to neuronal damage. Glutamate may also mediate neurotoxic effects of environmental toxic agents such as lead which amplify glutamate excitotoxicity. In these interactions, excessive activation of glutamate receptors and oxidative burst may converge into a common pathway leading to cell death through a cascade involving PKC or other protein important in oxidative burst in neurons.


Asunto(s)
Glutamina/toxicidad , Estrés Oxidativo , Animales , Apoptosis , Calcio/metabolismo , Humanos , Plomo/toxicidad , Proteína Quinasa C/fisiología
11.
Free Radic Biol Med ; 19(5): 689-93, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8529930

RESUMEN

Lead markedly amplified L-glutamate-induced oxidative stress, that is, increased L-glutamate-induced production of reactive oxygen species, decreased cellular glutathione, and induced cytotoxicity in human neuroblastoma cells. It was notable that oxidative burst induced by L-glutamate alone was observed only when neuronal glutathione was depleted. A role of protein kinase C (PKC) in glutamate-induced production of reactive oxygen species is likely because it was blocked by a PKC inhibitor. We suggest here that the mechanism whereby lead causes its neurotoxicity may be through the amplification of glutamate-induced oxidative stress, possibly through PKC activation.


Asunto(s)
Ácido Glutámico/farmacología , Glutatión/metabolismo , Plomo/farmacología , Compuestos Organometálicos/farmacología , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Línea Celular , Sinergismo Farmacológico , Humanos , Cinética , Neuroblastoma , Espectrometría de Fluorescencia , Factores de Tiempo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA